These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1612066)

  • 21. The effects of treatment on the direct costs of diabetes.
    Herman WH; Eastman RC
    Diabetes Care; 1998 Dec; 21 Suppl 3():C19-24. PubMed ID: 9850482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Reducing blood glucose values saves diabetic patients' eyes].
    Schloot NC
    MMW Fortschr Med; 2015 Jul; 157(13):40. PubMed ID: 26206032
    [No Abstract]   [Full Text] [Related]  

  • 23. Normoglycemic diabetic retinopathy and nephropathy.
    Schwartz NL; Mishal J; Viskoper R
    J Diabet Complications; 1987; 1(1):30-1. PubMed ID: 2968994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mixed messages on systemic therapies for diabetic retinopathy.
    Sauerhöfer SJ; Lammert A; Köppel H; Hammes HP; Krämer BK
    Lancet; 2010 Oct; 376(9751):1461; author reply 1462. PubMed ID: 21036264
    [No Abstract]   [Full Text] [Related]  

  • 25. Implications of the diabetes control and complications trial for renal outcomes and medical nutrition therapy.
    Delahanty LM
    J Ren Nutr; 1998 Apr; 8(2):59-63. PubMed ID: 9724486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycated protein update: implications of recent studies, including the diabetes control and complications trial.
    Benjamin RJ; Sacks DB
    Clin Chem; 1994 May; 40(5):683-7. PubMed ID: 8174238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is intensive glycemic control worth the expense?
    Eastman RC
    Cleve Clin J Med; 1997 Sep; 64(8):410-3. PubMed ID: 9308216
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent highlights of ATVB: diabetes mellitus.
    Schmidt AM
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):954-8. PubMed ID: 24740187
    [No Abstract]   [Full Text] [Related]  

  • 29. [Physiopathology and therapy of diabetes mellitus].
    Akanuma Y
    Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1645-56. PubMed ID: 10581743
    [No Abstract]   [Full Text] [Related]  

  • 30. Understanding the long-term benefits and dangers of intensive therapy of diabetes.
    Nathan DM
    Arch Intern Med; 2012 May; 172(10):769-70. PubMed ID: 22636821
    [No Abstract]   [Full Text] [Related]  

  • 31. Risks and benefits of intensive management in non-insulin-dependent diabetes mellitus. The Fifth Regenstrief Conference.
    Ann Intern Med; 1996 Jan; 124(1 Pt 2):81-186. PubMed ID: 8554218
    [No Abstract]   [Full Text] [Related]  

  • 32. Strict metabolic control and progression of incipient diabetic nephropathy.
    German MS; Karam JH
    Lancet; 1987 Apr; 1(8538):922. PubMed ID: 2882323
    [No Abstract]   [Full Text] [Related]  

  • 33. Improving inpatient glucose control.
    Fain JA
    Diabetes Educ; 2006; 32(3):291. PubMed ID: 16772647
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of diabetes mellitus after the DCCT--what's next?
    Nathan DM
    West J Med; 1995 May; 162(5):469-70. PubMed ID: 7785269
    [No Abstract]   [Full Text] [Related]  

  • 35. Type 1 diabetes--progress and prospects.
    The Lancet
    Lancet; 2014 Jan; 383(9911):2. PubMed ID: 24388295
    [No Abstract]   [Full Text] [Related]  

  • 36. Good news and bad news from San Diego.
    Kennedy MS;
    Am J Nurs; 2005 Aug; 105(8):29. PubMed ID: 16062051
    [No Abstract]   [Full Text] [Related]  

  • 37. Global reality of type 1 diabetes care in 2013.
    Beran D; Yudkin JS; Atkinson MA
    Diabetes Care; 2013 Sep; 36(9):e144. PubMed ID: 23970723
    [No Abstract]   [Full Text] [Related]  

  • 38. Comment on the DCCT report. Diabetes Control and Complications Trial.
    Engerman RL; Kern TS
    Diabetes; 1996 Feb; 45(2):270. PubMed ID: 8549874
    [No Abstract]   [Full Text] [Related]  

  • 39. Benefits of early intensive glucose control to prevent diabetes complications were sustained for up to 10 years.
    O'Sullivan EP; Dinneen SF
    Evid Based Med; 2009 Feb; 14(1):9-10. PubMed ID: 19181941
    [No Abstract]   [Full Text] [Related]  

  • 40. Diabetes: early initiation of intensive therapy might benefit children with type 2 diabetes mellitus.
    Barranco C
    Nat Rev Endocrinol; 2012 May; 8(7):382. PubMed ID: 22614716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.